©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Mar 26, 2019; 7(6): 742-752
Published online Mar 26, 2019. doi: 10.12998/wjcc.v7.i6.742
Published online Mar 26, 2019. doi: 10.12998/wjcc.v7.i6.742
Cardiac amyloidosis: A case report and review of literature
Adeyemi Adedamola Taiwo, Department of Internal Medicine, East Carolina University, Greenville, NC 27834, United States
Lavanya Alapati, Assad Movahed, Department of Cardiovascular Sciences, East Carolina Heart Institute, East Carolina University, Greenville, NC 27834, United States
Author contributions: Taiwo AA, Alapati L and Movahed A contributed to the manuscript writing.
Informed consent statement: Consent was obtained from the patient at the time of investigations, but not at the time of writing patient case report.
Conflict-of-interest statement: All authors declared there were no conflicts of interest involved.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016) and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Assad Movahed, MD, Attending Doctor, Professor, Department of Cardiovascular Sciences, East Carolina Heart Institute, East Carolina University, 115 Heart Drive, Greenville, NC 27834, United States. movaheda@ecu.edu
Telephone: +1-252-7444400 Fax: +1-252-7447724
Received: January 10, 2019
Peer-review started: January 10, 2019
First decision: January 26, 2019
Revised: February 12, 2019
Accepted: February 18, 2019
Article in press: February 18, 2019
Published online: March 26, 2019
Processing time: 75 Days and 5.1 Hours
Peer-review started: January 10, 2019
First decision: January 26, 2019
Revised: February 12, 2019
Accepted: February 18, 2019
Article in press: February 18, 2019
Published online: March 26, 2019
Processing time: 75 Days and 5.1 Hours
Core Tip
Core tip: Modern cardiovascular imaging techniques have facilitated earlier identification of cardiac amyloidosis, an important but under diagnosed cause of restrictive cardiomyopathy and heart failure. Early diagnosis is key as treatment strategies are emerging which have the potential to alter the disease course.